Eli Lilly Revenue 2006-2018 | LLY

Current and historical revenue for Eli Lilly (LLY) from 2006 to 2018. The sum of all revenue fields included for a company's operating activities. The current revenue for Eli Lilly as of March 31, 2018 is .
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $92.940B $22.871B
Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. They were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and they remain true to that mission in all their work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $337.858B 16.72
Pfizer (PFE) United States $223.411B 13.75
Novartis AG (NVS) Switzerland $182.569B 15.82
Merck (MRK) United States $169.563B 15.15
AbbVie (ABBV) United States $153.340B 15.64
Novo Nordisk (NVO) Denmark $121.883B 20.19
Sanofi (SNY) France $105.164B 13.31
GlaxoSmithKline (GSK) United Kingdom $103.492B 14.15
AstraZeneca (AZN) United Kingdom $94.122B 9.86
Bristol-Myers Squibb (BMY) United States $92.940B 18.28